Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 7 | 2024 | 1180 | 1.060 |
Why?
|
| Sleep | 8 | 2024 | 454 | 0.870 |
Why?
|
| Anti-Obesity Agents | 1 | 2021 | 13 | 0.790 |
Why?
|
| Diabetic Retinopathy | 3 | 2024 | 91 | 0.470 |
Why?
|
| Obesity | 5 | 2024 | 971 | 0.470 |
Why?
|
| Melatonin | 2 | 2024 | 50 | 0.450 |
Why?
|
| Sleep Apnea, Obstructive | 4 | 2023 | 217 | 0.410 |
Why?
|
| Obesity, Morbid | 2 | 2015 | 236 | 0.400 |
Why?
|
| Sleep Wake Disorders | 2 | 2023 | 117 | 0.400 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2023 | 107 | 0.380 |
Why?
|
| Bariatric Surgery | 2 | 2015 | 197 | 0.320 |
Why?
|
| Weight Loss | 2 | 2024 | 228 | 0.290 |
Why?
|
| Circadian Rhythm | 2 | 2024 | 304 | 0.270 |
Why?
|
| Insulin Resistance | 2 | 2020 | 353 | 0.230 |
Why?
|
| Retinal Ganglion Cells | 1 | 2024 | 71 | 0.220 |
Why?
|
| Actigraphy | 1 | 2023 | 59 | 0.210 |
Why?
|
| Point Mutation | 2 | 2000 | 245 | 0.210 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 191 | 0.200 |
Why?
|
| Weight Gain | 1 | 2021 | 119 | 0.190 |
Why?
|
| Life Style | 1 | 2021 | 173 | 0.180 |
Why?
|
| Glucose Intolerance | 2 | 2011 | 94 | 0.180 |
Why?
|
| Hyperthyroxinemia | 1 | 2000 | 17 | 0.180 |
Why?
|
| Consanguinity | 2 | 1999 | 73 | 0.170 |
Why?
|
| Meals | 1 | 2020 | 22 | 0.170 |
Why?
|
| Serum Albumin | 1 | 2000 | 127 | 0.170 |
Why?
|
| Energy Intake | 1 | 2020 | 99 | 0.170 |
Why?
|
| Blood Glucose | 2 | 2015 | 837 | 0.170 |
Why?
|
| Neurosecretory Systems | 2 | 2011 | 36 | 0.170 |
Why?
|
| Christianity | 1 | 1999 | 37 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2024 | 581 | 0.150 |
Why?
|
| Receptors, Thyrotropin | 4 | 1999 | 47 | 0.150 |
Why?
|
| Inflammation | 1 | 2023 | 975 | 0.150 |
Why?
|
| Iodide Peroxidase | 1 | 1999 | 205 | 0.140 |
Why?
|
| Feeding Behavior | 1 | 2020 | 327 | 0.140 |
Why?
|
| Mutation | 6 | 2000 | 4158 | 0.140 |
Why?
|
| Congenital Hypothyroidism | 3 | 2005 | 79 | 0.140 |
Why?
|
| Humans | 23 | 2024 | 89500 | 0.130 |
Why?
|
| Adult | 9 | 2024 | 26659 | 0.130 |
Why?
|
| Pedigree | 7 | 2005 | 970 | 0.120 |
Why?
|
| Male | 14 | 2024 | 42438 | 0.100 |
Why?
|
| Female | 15 | 2024 | 46328 | 0.100 |
Why?
|
| Appetite | 1 | 2011 | 26 | 0.100 |
Why?
|
| Ghrelin | 1 | 2011 | 29 | 0.100 |
Why?
|
| Leptin | 1 | 2011 | 102 | 0.090 |
Why?
|
| Metformin | 1 | 2012 | 124 | 0.090 |
Why?
|
| Risk | 1 | 2011 | 655 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 1722 | 0.080 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 2000 | 160 | 0.080 |
Why?
|
| Metabolic Syndrome | 1 | 2010 | 123 | 0.080 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 2 | 2000 | 117 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 351 | 0.080 |
Why?
|
| Homeostasis | 1 | 2011 | 417 | 0.080 |
Why?
|
| Risk Factors | 3 | 2023 | 5518 | 0.080 |
Why?
|
| United States | 1 | 2021 | 7033 | 0.080 |
Why?
|
| Genetic Linkage | 5 | 2005 | 624 | 0.080 |
Why?
|
| Thyrotropin | 3 | 1999 | 289 | 0.080 |
Why?
|
| Prevalence | 1 | 2011 | 1245 | 0.070 |
Why?
|
| Hypothyroidism | 2 | 1999 | 241 | 0.070 |
Why?
|
| Middle Aged | 7 | 2024 | 25971 | 0.070 |
Why?
|
| Child, Preschool | 5 | 2000 | 3753 | 0.070 |
Why?
|
| Sleep Deprivation | 1 | 2007 | 138 | 0.060 |
Why?
|
| Cyclic AMP | 2 | 1997 | 275 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2005 | 66 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 766 | 0.060 |
Why?
|
| Glucagon-Like Peptides | 1 | 2024 | 8 | 0.060 |
Why?
|
| Haplotypes | 4 | 1999 | 636 | 0.060 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2024 | 47 | 0.060 |
Why?
|
| Genotype | 4 | 2005 | 1852 | 0.060 |
Why?
|
| Adenoma | 2 | 1997 | 247 | 0.060 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2023 | 52 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2023 | 85 | 0.050 |
Why?
|
| Phenotype | 5 | 2000 | 2447 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2024 | 301 | 0.050 |
Why?
|
| Thyroid Neoplasms | 2 | 1997 | 425 | 0.050 |
Why?
|
| Triiodothyronine | 2 | 2000 | 344 | 0.050 |
Why?
|
| Thyroxine | 2 | 2000 | 353 | 0.050 |
Why?
|
| Aged | 4 | 2024 | 19124 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2024 | 774 | 0.050 |
Why?
|
| Switzerland | 1 | 2000 | 17 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2023 | 870 | 0.040 |
Why?
|
| Diet Records | 1 | 2020 | 19 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2020 | 39 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 338 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 146 | 0.040 |
Why?
|
| Goiter | 1 | 1999 | 43 | 0.040 |
Why?
|
| Homozygote | 1 | 1999 | 201 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2000 | 601 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2024 | 763 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 2876 | 0.040 |
Why?
|
| Intellectual Disability | 1 | 1999 | 189 | 0.040 |
Why?
|
| S-Nitrosothiols | 1 | 1997 | 5 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 5330 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2000 | 423 | 0.040 |
Why?
|
| Vasodilation | 1 | 1997 | 93 | 0.030 |
Why?
|
| Glycolysis | 1 | 1997 | 135 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 1999 | 1074 | 0.030 |
Why?
|
| Animals | 5 | 2010 | 27453 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 1997 | 279 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2015 | 158 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 1997 | 432 | 0.030 |
Why?
|
| DNA | 1 | 2000 | 1309 | 0.030 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 1993 | 2 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 6354 | 0.030 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 1993 | 11 | 0.030 |
Why?
|
| Mitochondria | 1 | 1997 | 553 | 0.030 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1993 | 39 | 0.030 |
Why?
|
| Angiotensin II | 1 | 1993 | 93 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2024 | 8200 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 1993 | 253 | 0.020 |
Why?
|
| Polysomnography | 1 | 2011 | 151 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 421 | 0.020 |
Why?
|
| Hospitalization | 1 | 2015 | 880 | 0.020 |
Why?
|
| Myocardium | 1 | 1993 | 572 | 0.020 |
Why?
|
| Base Sequence | 3 | 1999 | 2329 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 1172 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1072 | 0.020 |
Why?
|
| Chicago | 1 | 2012 | 1430 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1876 | 0.020 |
Why?
|
| Adolescent | 3 | 2011 | 9289 | 0.020 |
Why?
|
| Child | 4 | 1999 | 7210 | 0.020 |
Why?
|
| GTP-Binding Proteins | 2 | 1997 | 145 | 0.020 |
Why?
|
| Thyroid Gland | 2 | 1997 | 280 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2005 | 48 | 0.020 |
Why?
|
| Rabbits | 2 | 1997 | 639 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 529 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 2641 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6761 | 0.010 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1999 | 40 | 0.010 |
Why?
|
| Triiodothyronine, Reverse | 1 | 1999 | 32 | 0.010 |
Why?
|
| Receptors, Corticotropin | 1 | 1999 | 5 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 1999 | 22 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 743 | 0.010 |
Why?
|
| Prolactin | 1 | 1999 | 89 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2000 | 476 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 543 | 0.010 |
Why?
|
| Endocrine Glands | 1 | 1997 | 13 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2012 | 9097 | 0.010 |
Why?
|
| COS Cells | 1 | 1997 | 167 | 0.010 |
Why?
|
| Iodoacetic Acid | 1 | 1997 | 3 | 0.010 |
Why?
|
| Iodoacetates | 1 | 1997 | 4 | 0.010 |
Why?
|
| Amobarbital | 1 | 1997 | 5 | 0.010 |
Why?
|
| Uncoupling Agents | 1 | 1997 | 15 | 0.010 |
Why?
|
| Calcimycin | 1 | 1997 | 33 | 0.010 |
Why?
|
| Ionophores | 1 | 1997 | 14 | 0.010 |
Why?
|
| Rotenone | 1 | 1997 | 18 | 0.010 |
Why?
|
| Dinoprost | 1 | 1997 | 26 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1997 | 36 | 0.010 |
Why?
|
| Nitroglycerin | 1 | 1997 | 23 | 0.010 |
Why?
|
| Electron Transport | 1 | 1997 | 74 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 1999 | 357 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1997 | 232 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 1999 | 329 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1997 | 135 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1997 | 177 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1997 | 266 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1997 | 145 | 0.010 |
Why?
|
| Cysteine | 1 | 1997 | 137 | 0.010 |
Why?
|
| Cell Division | 1 | 1997 | 692 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1997 | 316 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1997 | 388 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 1048 | 0.010 |
Why?
|
| Aorta | 1 | 1997 | 289 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1997 | 508 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1993 | 403 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1993 | 92 | 0.010 |
Why?
|
| Infant | 1 | 1999 | 3173 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 1993 | 131 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 2062 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1997 | 2487 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1997 | 2021 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1993 | 497 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 996 | 0.010 |
Why?
|
| Rats | 1 | 1997 | 4040 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 3024 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1993 | 899 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1995 | 1158 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1993 | 465 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 1993 | 607 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1993 | 1928 | 0.000 |
Why?
|
| Mice | 1 | 2000 | 11812 | 0.000 |
Why?
|